ClinicalTrials.Veeva

Menu

A Registry Study on Primary/idiopathic Triglyceride Deposit Cardiomyovasculopathy

T

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Status

Completed

Conditions

Triglyceride Deposit Cardiomyovasculopathy

Study type

Observational

Funder types

Other

Identifiers

NCT05345223
20334(T2)-3

Details and patient eligibility

About

The objective of this study is to construct a registry; in order to understand the onset status of triglyceride deposit cardiomyovasculopathy (TGCV) in Japan with patients' background and natural history of the disease, and to explore disease-specific prognostic factors.

Enrollment

193 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients who have been confirmed as TGCV based on the diagnostic criteria for TGCV

Exclusion criteria

  • The patients who refused to participate in the study by opt-out

Trial design

193 participants in 1 patient group

TGCV
Description:
Patients who have been confirmed as TGCV by a cardiologist.

Trial contacts and locations

7

Loading...

Central trial contact

Ken-ichi Hirano, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems